578 related articles for article (PubMed ID: 9570994)
21. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone.
Zheng W; Lu JJ; Luo F; Zheng Y; Feng Yj; Felix JC; Lauchlan SC; Pike MC
Gynecol Oncol; 2000 Jan; 76(1):80-8. PubMed ID: 10620446
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of activin-beta A subunit mRNA is associated with decreased activin type II receptor mRNA levels in the testes of alpha-inhibin deficient mice.
Trudeau VL; Matzuk MM; Haché RJ; Renaud LP
Biochem Biophys Res Commun; 1994 Aug; 203(1):105-12. PubMed ID: 8074643
[TBL] [Abstract][Full Text] [Related]
23. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
[TBL] [Abstract][Full Text] [Related]
24. Production of activin A in hyperplasia and adenocarcinoma of the human endometrium.
Otani T; Minami S; Yamoto M; Umesaki N
Gynecol Oncol; 2001 Oct; 83(1):31-8. PubMed ID: 11585411
[TBL] [Abstract][Full Text] [Related]
25. Variation in pituitary expression of mRNAs encoding the putative inhibin co-receptor (betaglycan) and type-I and type-II activin receptors during the chicken ovulatory cycle.
Lovell TM; Knight PG; Gladwell RT
J Endocrinol; 2005 Sep; 186(3):447-55. PubMed ID: 16135664
[TBL] [Abstract][Full Text] [Related]
26. Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer.
Wilkinson SJ; Kucukmetin A; Cross P; Darby S; Gnanapragasam VJ; Calvert AH; Robson CN; Edmondson RJ
Hum Pathol; 2008 Aug; 39(8):1197-204. PubMed ID: 18495208
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE).
Choi KC; Kang SK; Nathwani PS; Cheng KW; Auersperg N; Leung PC
Mol Cell Endocrinol; 2001 Mar; 174(1-2):99-110. PubMed ID: 11306176
[TBL] [Abstract][Full Text] [Related]
28. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
[TBL] [Abstract][Full Text] [Related]
29. Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues.
van Schaik RH; Wierikx CD; Timmerman MA; Oomen MH; van Weerden WM; van der Kwast TH; van Steenbrugge GJ; de Jong FH
Br J Cancer; 2000 Jan; 82(1):112-7. PubMed ID: 10638976
[TBL] [Abstract][Full Text] [Related]
30. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.
Healy DL; Burger HG; Mamers P; Jobling T; Bangah M; Quinn M; Grant P; Day AJ; Rome R; Campbell JJ
N Engl J Med; 1993 Nov; 329(21):1539-42. PubMed ID: 8413476
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical localization of inhibin and activin subunits, activin receptors, and Smads in ovarian clear cell adenocarcinoma.
Mabuchi Y; Yamoto M; Minami S; Umesaki N
Oncol Rep; 2006 Feb; 15(2):291-6. PubMed ID: 16391844
[TBL] [Abstract][Full Text] [Related]
32. Ovarian regulation of endometrial gland morphogenesis and activin-follistatin system in the neonatal ovine uterus.
Carpenter KD; Hayashi K; Spencer TE
Biol Reprod; 2003 Sep; 69(3):851-60. PubMed ID: 12748121
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical localization of inhibin and activin subunits in human epithelial ovarian tumors.
Yamashita K; Yamoto M; Shikone T; Minami S; Nakano R
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):316-22. PubMed ID: 9988793
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of alpha-inhibin expression in the fetal ovary of estrogen-suppressed baboons is associated with impaired fetal ovarian folliculogenesis.
Billiar RB; Zachos NC; Burch MG; Albrecht ED; Pepe GJ
Biol Reprod; 2003 Jun; 68(6):1989-96. PubMed ID: 12606324
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of the expression of activin A in esophageal carcinoma.
Yoshinaga K; Mimori K; Yamashita K; Utsunomiya T; Inoue H; Mori M
Int J Oncol; 2003 Jan; 22(1):75-80. PubMed ID: 12469187
[TBL] [Abstract][Full Text] [Related]
36. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
[TBL] [Abstract][Full Text] [Related]
37. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome.
Roberts VJ; Barth S; el-Roeiy A; Yen SS
J Clin Endocrinol Metab; 1994 Nov; 79(5):1434-9. PubMed ID: 7962340
[TBL] [Abstract][Full Text] [Related]
38. Inhibin alpha and beta expression in ovarian stromal tumors and their histological equivalences.
Ciriş M; Erhan Y; Zekioglu O; Bayramoglu H
Acta Obstet Gynecol Scand; 2004 May; 83(5):491-6. PubMed ID: 15059165
[TBL] [Abstract][Full Text] [Related]
39. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.
Cathro HP; Stoler MH
Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumours of the ovary.
Arora DS; Cooke IE; Ganesan TS; Ramsdale J; Manek S; Charnock FM; Groome NP; Wells M
J Pathol; 1997 Apr; 181(4):413-8. PubMed ID: 9196439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
